Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Effects of Citrate Acid Concentrate on Hemodialysis Adequacy, Reuse, and Quality of Life: A Prospective Randomized
S P Nagaraju1, S Kosuru2, R Parthasarathy3
1Department of Nephrology, Kasturba Medical College, Manipal University, Udupi, Karnataka, India.
Insights
Citrate dialysate (CD) for hemodialysis improves dialyzer reuse but shows no significant difference in adequacy or quality of life compared to acetate dialysate (AD). CD is a safe alternative for end-stage renal disease patients.
Area of Science:
- Nephrology
- Renal Replacement Therapy
- Dialysis Technology
Background:
- Bicarbonate hemodialysis is a standard treatment for end-stage renal disease (ESRD).
- Acetate dialysate (AD) is commonly used, but citrate dialysate (CD) has been proposed as an alternative.
- The comparative benefits of CD versus AD regarding dialysis adequacy, dialyzer reuse, and patient quality of life require further investigation.
Purpose of the Study:
- To compare the efficacy and safety of citrate dialysate (CD) versus acetate dialysate (AD) in patients undergoing maintenance hemodialysis.
- To evaluate the impact of CD on hemodialysis adequacy, dialyzer reuse, and quality of life in ESRD patients.
- To assess secondary outcomes including intradialytic hypotension, acidosis correction, and hypocalcemia.
Main Methods:
- A 1-year, single-blinded, randomized prospective crossover trial involving 32 stable ESRD patients on twice-weekly hemodialysis.
- Patients were randomly assigned to receive either CD or AD fluid.
- Primary outcomes included hemodialysis adequacy (spKt/V, urea reduction ratio), dialyzer reuse, and quality of life. Secondary outcomes assessed intradialytic hypotension, acidosis, and hypocalcemia.
Main Results:
- A total of 28 patients completed 1456 sessions with CD and 1456 sessions with AD.
- Citrate dialysate (CD) significantly increased dialyzer reuse (P = 0.02).
- No significant differences were observed in hemodialysis adequacy (spKt/V, P = 0.840; urea reduction ratio, P = 0.90), quality of life, acidosis correction (pH, P = 0.23; bicarbonate, P = 0.17), or calcium levels (P = 0.16).
Conclusions:
- Citrate dialysate (CD) is a safe and equally effective alternative to acetate dialysate (AD) for bicarbonate hemodialysis.
- CD significantly enhances the potential for dialyzer reuse in hemodialysis patients.
- CD does not provide additional benefits regarding hemodialysis adequacy or overall quality of care compared to AD.
Abstract:
We conducted a randomized crossover trial to identify whether the use of citrate dialysate (CD) for bicarbonate hemodialysis is beneficial compared to regular acetate dialysate (AD) in terms of adequacy, reuse, and quality of life. Thirty-two stable end-stage renal disease patients on twice-weekly maintenance hemodialysis were randomly assigned to CD or AD fluid in a single-blinded randomized prospective crossover trial of 1-year duration. The primary outcomes studied were the impact of CD in comparison with AD on hemodialysis adequacy, reuse of dialyzer, and quality of life. Secondary outcomes studied were the effect on intradialytic hypotension, acidosis correction, and episodes of symptomatic hypocalcemia. A total number of 28 patients underwent a total of 1456 sessions of hemodialysis with CD over 6 months and 1456 sessions with AD over 6 months. There was a significant increase in dialyzer reuse with the use of CD (P = 0.02). There was no difference in dialyzer adequacy as measured by Single pool Kt/V (spKt/V) (P = 0.840) and urea reduction ratio (%) (P = 0.90). Quality of life did not differ between the two groups. No statistically significant difference was observed in predialysis arterial pH (P = 0.23) serum bicarbonate (0.17) and calcium change (P = 0.16). CD is safe and equally effective as compared to AD. It significantly improves the reuse of dialyzer but it does not offer any added advantage in terms of improvement in hemodialysis adequacy and quality of care.
Related Concept Videos
Radical Reactivity: Concentration Effects
Half-life of a Reaction
Substituent Effects on Acidity of Carboxylic Acids
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Hemodialysis I: Introduction
Characteristics of Life

